Scandinavian ChemoTech AB Series B Net Asset Quality Index
Scandinavian ChemoTech AB Series B net asset quality index. Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Net Asset Quality Index of 13.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr11.01 Million minus total liabilities of Skr9.49 Million yields net assets of Skr1.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Scandinavian ChemoTech AB Series B (CMOTEC-B) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Scandinavian ChemoTech AB Series B (2014–2025)
Net asset quality index of Scandinavian ChemoTech AB Series B from 2014 to 2025. This chart shows how Scandinavian ChemoTech AB Series B's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at 13.8%, representing net assets of Skr1.52 Million against total assets of Skr11.01 Million SEK. Check CMOTEC-B strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Scandinavian ChemoTech AB Series B Net Asset Quality Index by Year (2014–2025)
Scandinavian ChemoTech AB Series B net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Scandinavian ChemoTech AB Series B from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Scandinavian ChemoTech AB Series B worth.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 24.1% | Skr3.19 Million | Skr13.20 Million | Skr10.01 Million | ▼ -20.6 pp |
| 2024 | 44.7% | Skr5.98 Million | Skr13.38 Million | Skr7.40 Million | ▼ -29.5 pp |
| 2023 | 74.2% | Skr11.03 Million | Skr14.87 Million | Skr3.84 Million | ▲ +9.7 pp |
| 2022 | 64.5% | Skr13.99 Million | Skr21.70 Million | Skr7.71 Million | ▼ -28.2 pp |
| 2021 | 92.7% | Skr23.92 Million | Skr25.81 Million | Skr1.89 Million | ▲ +34.9 pp |
| 2020 | 57.8% | Skr9.24 Million | Skr15.99 Million | Skr6.75 Million | ▲ +2.1 pp |
| 2019 | 55.6% | Skr9.73 Million | Skr17.49 Million | Skr7.76 Million | ▼ -34.2 pp |
| 2018 | 89.9% | Skr20.50 Million | Skr22.81 Million | Skr2.31 Million | ▲ +9.8 pp |
| 2017 | 80.1% | Skr10.29 Million | Skr12.84 Million | Skr2.56 Million | ▼ -6.6 pp |
| 2016 | 86.7% | Skr14.58 Million | Skr16.83 Million | Skr2.24 Million | ▲ +73.6 pp |
| 2015 | 13.1% | Skr868.64K | Skr6.65 Million | Skr5.78 Million | ▼ -57.2 pp |
| 2014 | 70.2% | Skr46.27K | Skr65.90K | Skr19.63K | — |